fbpx
Study Confirms Stereotactic Ablative Radiotherapy Effectiveness for Early-Stage Lung Cancer

 

St. Louis CyberKnife Proudly Supports the Radiosurgical Research Institute The Radiosurgical Research Institute (RRI), a 501c3 public charity, is the only independent medical research organization committed to improving the outcomes of cancer patients treated with radiosurgery.  Its mission is to advance radiosurgery as a cancer treatment through innovation, education, and quality research in collaboration with […]

 

Learn More

 

 

St. Louis CyberKnife Proudly Supports the Radiosurgical Research Institute

 

The National Comprehensive Cancer Network® Supports SBRT for Prostate Cancer The National Comprehensive Cancer Network recently updated their patient guide that supports stereotactic body radiation therapy (SBRT) for prostate cancer.  The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and […]

 

Learn More

 

 

Study: Physical Activity Benefits Lung Cancer Patients and Survivors

 

A recent study published in the Journal of Thoracic Oncology reviewed the safety, benefits, and application of increasing physical activity and exercise in current and former lung cancer patients. The study sought to summarize the effect on improved outcomes, quality of life, symptom management and other factors. Authors of the study found that the majority of […]

 

Learn More

 

 

Patient Resources: Understanding Oligometastases and SBRT

 

A recent study presented at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) reported that stereotactic body radiation therapy (SBRT) benefits patients with advanced oligometastatic lung cancer. Oligometastasis, a form of metastatic cancer, is the intermediate state of metastasis. Metastatic cancer occurs when cancer cells break away from a primary tumor […]

 

Learn More

 

 

Men’s Health Week: Monitoring for Prostate Cancer

 

As the second leading cause of cancer death in American men, prostate cancer can greatly impact the lives of those diagnosed and their family and friends. During Men’s Health Week, celebrated this year from June 15 – 21, we encourage early detection and treatment of the disease. It is important for men and their loved […]

 

Learn More

 

 

CyberKnife Treatment for Recurrent Lung Cancer

 

In some cases, patients with recurrent lung tumors may have limited options. While a recurrent lung cancer diagnosis may cause feelings of shock and distress, patients can feel hopeful that there are options available to treat cancer that comes back in areas previously treated with surgery or radiation. At St. Louis CyberKnife, our team of […]

 

Learn More

 

 

Common CyberKnife Patient Questions

 

Read below for an overview of common CyberKnife® questions to learn more about the treatment. CyberKnife can treat brain tumors, lung tumors, prostate cancer, metastatic and recurrent cancer, and other types of cancerous and non-cancerous conditions. This is not intended as medical advice to replace the expertise and judgment of your health care team. It […]

 

Learn More

 

 

Cancer Terms to Know: Local Control

 

If you or a loved one is preparing to undergo cancer treatment and have been presented with various treatment options, one of the many medical terms you may have heard is “local control.” This term refers to cancer that hasn’t grown and progressed and remains at the original tumor site. Radiation is used for local […]

 

Learn More

 

 

Cancer Research Month: SBRT Shows Effectiveness for Early-Stage Lung Cancer

 

May is recognized as National Cancer Research Month by The American Association for Cancer Research in an effort to bring national attention to innovative cancer research advancing the fight against the disease. One recent study focused on stereotactic body radiation therapy (SBRT) demonstrated effectiveness for early-stage lung cancer, a common type of cancer that affects […]

 

Learn More

 

 

Studies Show Support for CyberKnife Treatment of Neurological Diseases

 

A study presented at the annual meeting of the European Association of Neurosurgical Societies (EANS) demonstrated the growing support of CyberKnife® for the treatment of neurological diseases. The study, completed at the University Hospital of Messina in Italy, examined CyberKnife treatment for perioptic meningioma, a type of benign tumor that arises from the membranes that […]

 

Learn More